Cargando…

789. Comparison of Interferon-γ Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients

BACKGROUND: Patients with certain types of cancer are at increased risk for progression from latent tuberculosis infection (LTBI) to active tuberculosis (ATB) because of immunosuppression. The purpose of this study was to compare the utility of the two commonly used IGRAs, QuantiFERON-TB Gold(®) (QF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulkarni, Prathit, Kmeid, Joumana, Batista, Marjorie, Chaer, Firas El, Ariza-Heredia, Ella, Graviss, Edward A, Mulanovich, Victor E, Chemaly, Roy F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254052/ http://dx.doi.org/10.1093/ofid/ofy210.796

Ejemplares similares

Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006–2014
por: Kmeid, Joumana, et al.
Publicado: (2019)

Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes
por: El Chaer, Firas, et al.
Publicado: (2017)

1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Artau, Annette, et al.
Publicado: (2018)

Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis
por: Tang, Jinhua, et al.
Publicado: (2021)

1476 Screening for Latent Tuberculosis Infection in Internationally Adopted Children in the era of Interferon-Gamma Release Assay (IGRA) Testing
por: Dhar, Cherie Priya, et al.
Publicado: (2014)

Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes
por: Spallone, Amy, et al.
Publicado: (2022)

1377. Use of Interferon-Gamma Release Assays (IGRAs) Reduced Latent Tuberculosis Infection (LTBI) Diagnosis in Refugee and Immigrant Children
por: Kushner, Lauren E, et al.
Publicado: (2019)

Screening for tuberculosis and the use of a borderline zone for the interpretation of the interferon-γ release assay (IGRA) in Portuguese healthcare workers
por: Nienhaus, Albert, et al.
Publicado: (2013)

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies
por: Vakil, Erik, et al.
Publicado: (2018)

Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance
por: Szturmowicz, Monika, et al.
Publicado: (2021)

Infliximab Therapy Leading to Pulmonary Tuberculosis in a Patient With Negative Interferon γ Release Assay (IGRA)-Based QuantiFERON Gold Test
por: Parita, Soni, et al.
Publicado: (2017)

1344. Interferon Gamma Release Assay (IGRA) Responses in HIV-Infected and -Uninfected Women in Pregnancy
por: Kaplan, Samantha, et al.
Publicado: (2019)

Utility of the Enzyme-Linked Immunospot Interferon-γ–Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2016)

The Challenging Evaluation of Patients with Severe Psoriasis for Latent Tuberculosis: An Important Indication for IGRA
por: Katsenos, Stamatis, et al.
Publicado: (2011)

Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results
por: Maharani, Winni, et al.
Publicado: (2020)

1583. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
por: Khawaja, Fareed, et al.
Publicado: (2018)

Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA
por: Jeong, Dae Hyun, et al.
Publicado: (2018)

Serial Interferon-Gamma Release Assay (IGRA) Testing to Monitor Treatment Responses in Cases of Feline Mycobacteriosis
por: Mitchell, Jordan L., et al.
Publicado: (2021)

Neutrophil CD64 expression levels in IGRA-positive individuals distinguish latent tuberculosis from active disease
por: Corrêa, Raquel da Silva, et al.
Publicado: (2019)

Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting
por: Sharma, Surendra K., et al.
Publicado: (2017)

Tympanoplasty Outcomes: A Review of 789 Cases
por: Indorewala, Shabbir, et al.
Publicado: (2015)

655. Patterns of Interferon-Gamma Release Assay (IGRA) Testing for Tuberculosis in Patients Less Than 2 Years Old
por: Tabatneck, Mary, et al.
Publicado: (2021)

Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review
por: Kmeid, Joumana, et al.
Publicado: (2015)

What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis
por: Agrawal, Rupesh, et al.
Publicado: (2017)

Estimating Latent Tuberculosis Infection Using Interferon-γ Release Assay, Japan
por: Nishimura, Tomoyasu, et al.
Publicado: (2018)

789 Association of food deserts and coronavirus severity in pregnancy
por: Sung, Juliana, et al.
Publicado: (2021)

Evaluation of the performance of two tuberculosis interferon gamma release assays (IGRA-ELISA and T-SPOT.TB) for diagnosing Mycobacterium tuberculosis infection
por: Wang, Linchuan, et al.
Publicado: (2018)

Detection of tuberculosis in cynomolgus macaques (Macaca fascicularis) using a supplementary Monkey Interferon Gamma Releasing Assay (mIGRA)
por: Warit, S., et al.
Publicado: (2020)

Immune-mediated inflammatory diseases differently affect IGRAs’ accuracy for latent tuberculosis infection diagnosis in clinical practice
por: Latorre, Irene, et al.
Publicado: (2017)

A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea
por: Hur, Yun-Gyoung, et al.
Publicado: (2019)

How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
por: El Chaer, Firas, et al.
Publicado: (2022)

Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children
por: Yun, Ki Wook, et al.
Publicado: (2016)

Edition Eulenburg No. 789, Horn Concerto, : E♭ majeur - E♭ major - Es dur KV 447 /

Correction to Lancet Rheumatol 2021; 3: e789–97
Publicado: (2022)

The association between diabetes status and latent-TB IGRA levels from a cross-sectional study in eastern China
por: Chen, Cheng, et al.
Publicado: (2023)

IGRA based diagnosis of infection and prediction of disease
por: Andersen, Peter
Publicado: (2010)

1390. A Novel Application of the Interferon-Gamma Release Assay (IGRA) Among End-Stage Heart Failure Patients Awaiting Heart Transplantation
por: Tsai, Ming-Jui, et al.
Publicado: (2019)

Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015
por: Nguyen, Duc T., et al.
Publicado: (2018)

High IFN-γ Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis
por: Carrère-Kremer, Séverine, et al.
Publicado: (2016)

Significant difference in Th1/Th2 paradigm induced by tuberculosis-specific antigens between IGRA-positive and IGRA-negative patients
por: Li, Qiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_usqrdau2g04gi3tfn9n2qi6bve